TrialJournal of neuro-oncology2018

Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial).

Supriya Mallick et al.PubMed ↗Publisher ↗

No numbers read from the abstract.